Haisco Pharmaceutical Group Co., Ltd.

Haisco Pharmaceutical Group Co., Ltd.verified

002653.SZ

Price:

$53.2

Market Cap:

$59.58B

Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers small-volume injections, freeze-dried powder injections, powder injections, large-volume injections, active pharmaceutical ingredient, etc. for various therapeutic fields, including anti-infective, digestive system, blood system, nervous system, parenteral nutrition, antibiotics, first aid, anesthetics, and tumor; and tablets, capsules, granules, and ointments in the fields of cardiovascular, anti-infection, digestive system, CNS system, diabetes, and hepatic diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed...[Read more]

Industry

Biotechnology

IPO Date

2012-01-17

Stock Exchange

SHZ

Ticker

002653.SZ

The Enterprise Value as of December 2025 (TTM) for Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) is 60.50B

According to Haisco Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 60.50B. This represents a change of 27.59% compared to the average of 47.42B of the last 4 quarters.

Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) Historical Enterprise Value (quarterly & annually)

How has 002653.SZ Enterprise Value performed in the past?

The mean historical Enterprise Value of Haisco Pharmaceutical Group Co., Ltd. over the last ten years is 21.63B. The current 60.50B Enterprise Value has changed 27.87% with respect to the historical average. Over the past ten years (40 quarters), 002653.SZ's Enterprise Value was at its highest in in the September 2025 quarter at 60.79B. The Enterprise Value was at its lowest in in the December 2017 quarter at 11.24B.

Quarterly (TTM)
Annual

Average

21.63B

Median

22.30B

Minimum

11.14B

Maximum

37.35B

Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Haisco Pharmaceutical Group Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 75.99%

Maximum Annual Enterprise Value = 37.35B

Minimum Annual Increase = -32.07%

Minimum Annual Enterprise Value = 11.14B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202437.35B38.38%
202326.99B6.86%
202225.26B11.58%
202122.64B16.75%
202019.39B-11.72%
201921.96B75.99%
201812.48B12.06%
201711.14B-32.07%
201616.39B-27.82%
201522.71B26.69%

Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) Average Enterprise Value

How has 002653.SZ Enterprise Value performed in the past?

The current Enterprise Value of Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

29.87B

5-year avg

26.33B

10-year avg

21.63B

Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) Enterprise Value vs. Peers

How is 002653.SZ’s Enterprise Value compared to its peers?

Haisco Pharmaceutical Group Co., Ltd.’s Enterprise Value is less than Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (64.67B), greater than Chongqing Zhifei Biological Products Co., Ltd. (57.30B), greater than Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (56.67B), greater than RemeGen Co Ltd (45.40B), greater than Pharmaron Beijing Co., Ltd. (47.79B), greater than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (37.25B), greater than Shanghai Allist Pharmaceuticals Co., Ltd. (44.48B), less than Shanghai Pharmaceuticals Holding Co., Ltd (91.18B), less than Shenzhen Salubris Pharmaceuticals Co., Ltd. (62.24B), greater than Shanghai RAAS Blood Products Co., Ltd. (42.99B),

Build a custom stock screener for Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Haisco Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Haisco Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Haisco Pharmaceutical Group Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Haisco Pharmaceutical Group Co., Ltd. (002653.SZ)?

What is the 3-year average Enterprise Value for Haisco Pharmaceutical Group Co., Ltd. (002653.SZ)?

What is the 5-year average Enterprise Value for Haisco Pharmaceutical Group Co., Ltd. (002653.SZ)?

How does the current Enterprise Value for Haisco Pharmaceutical Group Co., Ltd. (002653.SZ) compare to its historical average?